| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 10/10/2002 | CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/10/2002 | CA2440164A1 Preparation of ketones from aldehydes |
| 10/09/2002 | EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/09/2002 | CN1373754A Antibacterial agents |
| 10/09/2002 | CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide |
| 10/09/2002 | CN1092189C Substd. isoxazolines, process for producing them, agent contg. them and their use as safeners |
| 10/09/2002 | CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides |
| 10/08/2002 | USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them |
| 10/08/2002 | US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 10/08/2002 | US6462043 Method for producing substituted-2-nitroguanidine derivatives |
| 10/03/2002 | WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity |
| 10/03/2002 | US20020143024 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer |
| 10/03/2002 | US20020143020 Novel piperazine derivatives |
| 10/03/2002 | US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 10/03/2002 | US20020142000 Genetic engineering |
| 10/01/2002 | US6458960 Sulfonamide derivatives |
| 10/01/2002 | US6458805 Antagonists; especially sodium salts |
| 10/01/2002 | CA2241845C 4,5-dihydronaphth¬1,2-c|isoxazoles and derivatives thereof having cns activity |
| 10/01/2002 | CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists |
| 09/27/2002 | CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/25/2002 | EP1242427A1 Novel piperidine and piperazine derivatives |
| 09/25/2002 | EP1242416A1 Substituted isoxazolines and their use as antibacterial agents |
| 09/25/2002 | EP1242412A2 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles |
| 09/25/2002 | EP1242395A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 09/25/2002 | EP1242394A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
| 09/25/2002 | EP1242393A1 Herbicidal 3-(4,5-dihydroisoxazole-3-yl)-substituted benzoylcyclohexenone derivatives |
| 09/25/2002 | EP1242077A1 Novel processes for making- and a new crystalline form of- leflunomide |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/19/2002 | WO2002072559A1 Process to intermediates for biologically active compounds |
| 09/19/2002 | WO2002072527A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
| 09/19/2002 | US20020133020 Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| 09/19/2002 | US20020132838 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 09/19/2002 | DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
| 09/19/2002 | CA2441088A1 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/18/2002 | EP1240163A1 3-(4,5-dihydroisoxazole-5-yl)benzoylpyrazole |
| 09/18/2002 | EP0917528B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/17/2002 | US6452011 Process for production of piperidine derivatives |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
| 09/17/2002 | US6451829 Coumarinic compounds having IgE affecting properties |
| 09/17/2002 | CA2007332C Use of a glycine b partial agonist as an antipsychotic |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070495A1 Process for the preparation of 1,2-benzisoxazole-3-acetic acid |
| 09/12/2002 | WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | CA2440030A1 Process for the preparation of 1,2-benzisoxazole-3-acetic acid |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237881A1 Herbicidal halogenalkyl-substituted 3-(4,5-dihydroisoxazol-3-yl)-benzoyl-cyclohexenones |
| 09/11/2002 | EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 09/11/2002 | CN1368965A Isoxazoline derivatives and herbicides containing same as active ingredient |
| 09/10/2002 | US6448443 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 09/10/2002 | US6448406 Improved process for preparation of terfenadine carboxylic acid metabolite and carebastine derivatives; histamine h1 receptor blocking and calcium antagonists; respiratory, allergic, and cardiovascular disease states |
| 09/10/2002 | US6448201 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation, and their use as herbicides and plant growth regulators |
| 09/10/2002 | CA2240946C Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors |
| 09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| 09/05/2002 | DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus |
| 09/04/2002 | EP1235816A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | CN1367776A Process for preparing substituted cyclopentane derivatives and novel crystalline structures |
| 09/04/2002 | CN1367730A Homogenization enhancing thermoplastic foam extrusion screw |
| 09/03/2002 | US6444827 From beta-methyl l-aspartate via chemical intermediate; efficiency; antidiabetic agents |
| 08/29/2002 | WO2002066484A1 Isoxazoline derivatives as anti-depressants |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119983 Novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/28/2002 | EP1234819A1 Processes for production of oxadiazoline derivatives |
| 08/28/2002 | EP1054874B1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials |
| 08/28/2002 | CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441014 Antiinflammatory agent, useful for treating cylcoocygenase-2 associated disorders |
| 08/27/2002 | US6440963 Use of selective COX-2 inhibitors for the treatment of urinary incontinence |
| 08/22/2002 | WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/21/2002 | EP1231939A2 Oncolytic combinations for the treatment of cancer |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436930 Thio derivatives of sordarin as antifungal agents |
| 08/15/2002 | WO2002062770A1 Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062389A1 Remedies for urinary diseases comprising lpa receptor controlling agents |